Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)
Condition: Alport Syndrome, X-Linked Interventions: Drug: Hydroxychloroquine Sulfate 100 milligram (mg) Tab; Drug: Benazepril hydrochloride 10 milligram (mg) Tab Sponsor: Shanghai Children's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2021 Category: Research Source Type: clinical trials
Traditional Chinese medicine versus regular therapy in Henoch-Sch önlein purpura nephritis in children: study protocol for a randomized controlled trial
This study was performed to evaluate the curative effect and safety of a traditional Chinese me dicine (TCM) integrated treatment program in this type of HSPN.MethodsThis multicenter, open-label, large-sample, randomized controlled trial was performed in China and included 500 children with HSPN exhibiting mild pathological patterns. The treatment group to control group ratio was 2:1, and each group was further stratified into two types, light and heavy, according to urinary protein quantification and pathological type. The treatment group received tripterygium glycosides (TGs), tanshinone IIa sodium sulfonate injection, a...
Source: Trials - August 28, 2019 Category: Research Source Type: clinical trials
Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
Conditions: Hypertension; Unspecified Adult Solid Tumor, Protocol SpecificInterventions: Drug: lisinopril; Drug: losartan potassium; Other: laboratory biomarker analysis; Drug: benazepril hydrochloride; Drug: ramiprilSponsor: Comprehensive Cancer Center of Wake Forest UniversityTerminated - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2010 Category: Research Source Type: clinical trials
